PSUSA/00000745/202412
Submitted by Anonymous (not verified) on 23 October 2025 - 16:19
PSUSA/00000745/202412
Herbal medicinal product: Primulae radix, Primula veris L.,Primula elatior (L.) Hill, F: Assessment finalised
Submitted by Anonymous (not verified) on 23 October 2025 - 16:16
Herbal medicinal product: Primulae radix, Primula veris L.,Primula elatior (L.) Hill, F: Assessment finalised
Herbal medicinal product: Primulae flos, Primula veris L.,Primula elatior (L.) Hill, F: Assessment finalised
Submitted by Anonymous (not verified) on 23 October 2025 - 16:15
Herbal medicinal product: Primulae flos, Primula veris L.,Primula elatior (L.) Hill, F: Assessment finalised
Clinical Trial Information System (CTIS) structured data form - Notifications, Annual Safety Report (ASR) and results
Submitted by Anonymous (not verified) on 23 October 2025 - 15:27
Clinical Trial Information System (CTIS) structured data form - Notifications, Annual Safety Report (ASR) and results
Minutes of the COMP meeting 9-11 September 2025
Submitted by Anonymous (not verified) on 23 October 2025 - 15:07
Minutes of the COMP meeting 9-11 September 2025
Human medicines European public assessment report (EPAR): Amtagvi, lifileucel, Status: Application withdrawn
Submitted by Anonymous (not verified) on 23 October 2025 - 15:00
Human medicines European public assessment report (EPAR): Amtagvi, lifileucel, Status: Application withdrawn
Non-human primates in safety testing of human medicinal products and opportunities for 3Rs implementation - Scientific guideline
Submitted by Anonymous (not verified) on 23 October 2025 - 14:33
Non-human primates in safety testing of human medicinal products and opportunities for 3Rs implementation - Scientific guideline
Reflection paper on non-human primates in safety testing of human medicinal products and opportunities for 3Rs implementation
Submitted by Anonymous (not verified) on 23 October 2025 - 14:32
Reflection paper on non-human primates in safety testing of human medicinal products and opportunities for 3Rs implementation
Human medicines European public assessment report (EPAR): Tofidence, tocilizumab, Date of authorisation: 20/06/2024, Revision: 3, Status: Authorised
Submitted by Anonymous (not verified) on 23 October 2025 - 14:22
Human medicines European public assessment report (EPAR): Tofidence, tocilizumab, Date of authorisation: 20/06/2024, Revision: 3, Status: Authorised
PSUSA/00002737/202501
Submitted by Anonymous (not verified) on 23 October 2025 - 12:57
PSUSA/00002737/202501